Related Experiment Videos
[Oncogenes and tumor suppressor genes in the pathogenesis of lung tumors]
T Wiethege1, B Voss, K M Müller
1Institut für Pathologie, Berufsgenossenschaftliche Kliniken Bergmannsheil, Bochum.
Abstract:
The recent results obtained from investigations based on molecular biological techniques have led to a better understanding of recurrent genetic causes important for the pathogenesis of tumors. Several genes have been identified as being involved in the development of cancer. In many cases, the activation of oncogenes or the inactivation of tumor-suppressor genes is the predominant reason for cancerogenic cell transformation. Functional dysregulation is frequently the consequence of mutations, resulting in an alteration of the primary structure of the DNA. As our understanding of the nature, function, and interaction of these genes evolves, new opportunities for early diagnosis, classification, prevention, and treatment of malignant tumors will arise. The present report summarizes the current molecular biological aspects of several oncogenes (erbB, ras, myc, raf, fos, jun, bcl, mdm2, myb, kit CSF1R, met) and tumor suppressor genes (p53, rb, mts) involved in lung-cancer development with respect to the pathology of lung tumors, including the importance of these genes as far as the clinical course of the disease is concerned.
Insights
Understanding cancer pathogenesis is advancing through molecular biology. This research details key oncogenes and tumor suppressor genes involved in lung cancer development and clinical outcomes.
Area of Science:
- Molecular biology
- Genetics
- Oncology
Context:
- Tumorigenesis is driven by genetic alterations.
- Oncogene activation and tumor suppressor gene inactivation are critical.
- Mutations in DNA lead to functional gene dysregulation.
Purpose:
- To review molecular aspects of oncogenes and tumor suppressor genes in lung cancer.
- To correlate gene function with lung tumor pathology and clinical course.
Summary:
- Identifies key oncogenes (e.g., erbB, ras, myc) and tumor suppressor genes (e.g., p53, rb).
- Explains their role in lung cancer pathogenesis through molecular mechanisms.
- Discusses the impact of these genetic factors on lung tumor pathology and disease progression.
Impact:
- Advances understanding of lung cancer molecular basis.
- Provides foundation for improved early diagnosis and targeted therapies.
- Highlights the significance of genetic profiling in clinical management.